Tag: gastric cancer statistics

Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study

Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…

ME Desk